NYSE:SOLV Solventum (SOLV) Stock Price, News & Analysis $72.68 +0.55 (+0.76%) (As of 11:13 AM ET) Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Solventum Stock (NYSE:SOLV) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Key Stats Today's Range$72.30▼$73.2350-Day Range$48.22▼$72.3352-Week Range$47.16▼$96.05Volume170,975 shsAverage Volume1.12 million shsMarket Capitalization$12.55 billionP/E RatioN/ADividend YieldN/APrice Target$58.25Consensus RatingReduce Company OverviewSolventum Corporation, a healthcare company, engages in the developing, manufacturing, and commercializing a portfolio of solutions to address critical customer and patient needs. It operates through four segments: Medsurg, Dental Solutions, Health Information Systems, and Purification and Filtration. The Medsurg segment is a provider of solutions including advanced wound care, I.V. site management, sterilization assurance, temperature management, surgical supplies, stethoscopes, and medical electrodes. The Dental Solutions segment provides a comprehensive suite of dental and orthodontic products including brackets, aligners, restorative cements, and bonding agents. The Health Information Systems provides software solutions including computer-assisted, physician documentation, direct-to-bill and coding automation, classification methodologies, speech, recognition, and data visualization platforms. The Purification and Filtration segment provides purification and filtration technologies including filters, purifiers, cartridges, and membranes. The company was incorporated in 2023 and is based in Saint Paul, Minnesota.Read More… Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute (Ad)Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.This means you must act NOW before it's too late. Solventum Stock Analysis - MarketRank™See Top Rated MarketRank™ StocksOverall MarketRank™: 23rd PercentileSolventum scored higher than 23% of companies evaluated by MarketBeat, and ranked 895th out of 1,007 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion1.9 / 5Analyst RatingReduce Consensus RatingSolventum has received a consensus rating of Reduce. The company's average rating score is 1.86, and is based on no buy ratings, 6 hold ratings, and 1 sell rating.Amount of Analyst CoverageSolventum has been the subject of 6 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Solventum's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-11.44% Earnings GrowthEarnings for Solventum are expected to decrease by -11.44% in the coming year, from $6.38 to $5.65 per share.Price to Earnings Growth RatioSolventum has a PEG Ratio of 1.54. PEG Ratios above 1 indicate that a company could be overvalued.Read more about Solventum's valuation and earnings. Short Interest3.0 / 5Short Interest LevelHealthy Percentage of Shares Shorted3.87% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently increased by 1.33%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldSolventum does not currently pay a dividend.Dividend GrowthSolventum does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted3.87% of the float of Solventum has been sold short.Short Interest Ratio / Days to CoverSolventum has a short interest ratio ("days to cover") of 3.5, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in Solventum has recently increased by 1.33%, indicating that investor sentiment is decreasing. News and Social Media2.9 / 5News Sentiment1.16 News SentimentSolventum has a news sentiment score of 1.16. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.59 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 9 news articles for Solventum this week, compared to 6 articles on an average week.Search InterestOnly 16 people have searched for SOLV on MarketBeat in the last 30 days. This is a decrease of 0% compared to the previous 30 days.MarketBeat FollowsOnly 7 people have added Solventum to their MarketBeat watchlist in the last 30 days. This is a decrease of -22% compared to the previous 30 days. Company OwnershipN/AInsider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Solventum insiders have not sold or bought any company stock.Read more about Solventum's insider trading history. SOLV Stock News HeadlinesChina eyes multiple records as it hosts the FDI World Dental Congress in Shanghai in 2025September 19 at 12:37 AM | finance.yahoo.comWhat the Options Market Tells Us About 3MSeptember 16 at 7:16 PM | benzinga.comThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start with diversification and experience. Founded in 2005, this company serves a diverse and expansive customer base with more than 8,000 retail locations, including licensed cannabis dispensaries, smoke shops, and specialty retailers. September 19, 2024 | Greenlane (Ad)Bank of America Securities Keeps Their Hold Rating on Solventum Corporation (SOLV)September 13, 2024 | markets.businessinsider.comWhat’s Driving The Rebound In 3M Stock?September 10, 2024 | forbes.comSolventum Launches All-In-One, Extended-Wear Wound Dressing for V.A.C.® TherapySeptember 10, 2024 | prnewswire.comAnalysts Set Solventum Co. (NYSE:SOLV) Price Target at $58.25September 10, 2024 | americanbankingnews.comSolventum Corporation: Navigating Growth and Profitability with a Hold RatingSeptember 9, 2024 | markets.businessinsider.comSee More Headlines SOLV Stock Analysis - Frequently Asked Questions How have SOLV shares performed this year? Solventum's stock was trading at $66.90 at the beginning of 2024. Since then, SOLV shares have increased by 7.8% and is now trading at $72.13. View the best growth stocks for 2024 here. How were Solventum's earnings last quarter? Solventum Co. (NYSE:SOLV) issued its quarterly earnings results on Thursday, August, 8th. The company reported $1.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.46 by $0.10. The company's quarterly revenue was up .2% on a year-over-year basis. Who are Solventum's major shareholders? Solventum's top institutional shareholders include Davis Selected Advisers (2.99%), Nuance Investments LLC (1.27%), Newport Trust Company LLC (1.08%) and Baupost Group LLC MA (1.05%). How do I buy shares of Solventum? Shares of SOLV stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. Company Calendar Last Earnings8/08/2024Today9/19/2024Next Earnings (Estimated)11/14/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorMedical Industry Surgical & medical instruments Sub-IndustryMedical Equipment Current SymbolNYSE:SOLV Previous Symbol: CUSIPN/A CIK1964738 Webwww.solventum.com Phone651-733-1110FaxN/AEmployees22,000Year FoundedN/APrice Target and Rating Average Stock Price Target$58.25 High Stock Price Target$64.00 Low Stock Price Target$54.00 Potential Upside/Downside-20.0%Consensus RatingReduce Rating Score (0-4)1.86 Research Coverage7 Analysts Profitability EPS (Most Recent Fiscal Year)N/A Trailing P/E RatioN/A Forward P/E Ratio11.42 P/E Growth1.54Net IncomeN/A Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on AssetsN/A Debt Debt-to-Equity Ratio2.90 Current Ratio1.31 Quick Ratio0.96 Sales & Book Value Annual Sales$8.25 billion Price / Sales1.52 Cash FlowN/A Price / Cash FlowN/A Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares172,710,000Free FloatN/AMarket Cap$12.58 billion OptionableOptionable BetaN/A This page (NYSE:SOLV) was last updated on 9/19/2024 by MarketBeat.com Staff From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | SponsoredMan who Predicted Trump 2016 Win: “Prepare for Election Meltdown”Former advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemTaiwan Semiconductor, a partner of Nvidia’s for more than two decades, has seen its shares explode as much as ...Weiss Ratings | SponsoredBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist My Default Watchlist Adding Solventum Co. You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Please log in to your account or sign up in order to add this asset to your watchlist. Share Solventum With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.